Researchers have been excited about Retatrutide , a innovative dual agonist showing promising outcomes in clinical trials for weight loss . It works by modulating several pathways : GLP-1 and GIP, these, when stimulated, support control cravings and boost energy expenditure . Preliminary reports indicate considerable retatrutide coa weight reductio